The purpose of this study is to evaluate the efficacy of sunobinop compared to placebo on alcohol consumption in subjects with alcohol use disorder.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
200
1 tablet taken orally at bedtime
1 tablet taken orally at bedtime
Belmont Medical Office
Brooklyn, New York, United States
RECRUITINGOhio Clinical Trials
Columbus, Ohio, United States
RECRUITINGInquest Clinical Research
Baytown, Texas, United States
Percent heavy drinking days (HDD)
Time frame: Day 57
Number of standard unit drinks
Time frame: Day 57
Percent of drinking days (PDD)
Time frame: Day 57
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Cebis Usa, Llc
Houston, Texas, United States
RECRUITINGBio Terra Med SRL
Bucharest, Romania
RECRUITINGSpitalul Universitar De Urgenta Militar Central "Dr. Carol Davila"
Bucharest, Romania
RECRUITINGCabinet Medical Individual Dr. Andreea Popa
Bucharest, Romania
RECRUITING